C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C12N 15/113 (2010.01)
Patent
CA 2695868
This invention provides a method for predicting the post-treatment survival prospect of a cancer patient based on the expression level(s) of microRNAs hsa-miR137, hsa-miR372, hsa-miR182*, hsa- miR221, and hsa-let-7a in that cancer patient.
La présente invention concerne un procédé permettant de prédire la perspective de survie après traitement d'un patient cancéreux basé sur le(s) niveau(x) d'expression de micro-ARN hsa-miR137, hsa-miR372, hsa-miR182*, hsa-miR221, et hsa-let-7a chez le patient cancéreux.
Chang Gee-Chen
Chen Chih-Yi
Chen Hsuan-Yu
Chen Jian-Wei
Yang Pan-Chyr
Dcb-Usa Llc
Gowling Lafleur Henderson Llp
National Taiwan University
LandOfFree
Predicting post-treatment survival in cancer patients with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predicting post-treatment survival in cancer patients with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predicting post-treatment survival in cancer patients with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1465133